| Not Yet Recruiting | Duke Cardiometabolic Prevention Clinic's Impact on High-risk Cardiovascular Patients With Uncontrolled Risk Fa NCT07117695 | Duke University | N/A |
| Not Yet Recruiting | Development and Multicenter Validation of an AI-Based Remote Photoplethysmography (rPPG) Facial Scan for Multi NCT07491978 | Tarumanagara University | — |
| Not Yet Recruiting | Adherence to Dyslipidemia Therapy: Harnessing Evidence From Randomized Evaluations in AtheroSclerotic CardioVa NCT07522645 | Kaiser Permanente | N/A |
| Recruiting | Effects of IL-1 Beta Inhibition on Vascular Inflammation in TET2 Clonal Hematopoiesis NCT06691217 | Massachusetts General Hospital | Phase 2 |
| Not Yet Recruiting | Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis NCT07303777 | Atom Therapeutics Co., Ltd | Phase 2 |
| Active Not Recruiting | INcreTin-based thERapies for Cardiovascular Event PrevenTion in Patients With and Without ASCVD (INTERCEPT-ASC NCT07417618 | Brigham and Women's Hospital | — |
| Recruiting | The Long-term Effect of Remote Ischemic Conditioning on Main Organs in ASVCD Patients With Very High Risks NCT07270887 | General Hospital of Shenyang Military Region | — |
| Enrolling By Invitation | Improving Lipid Optimization Quality and Treatment Options in ASCVD NCT06960655 | Brigham and Women's Hospital | N/A |
| Active Not Recruiting | ACHIEVE Pilot Statins for Vascular Protection NCT06551701 | Duke University | — |
| Recruiting | Comparison of Pitavastatin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes M NCT06767774 | Korea University Anam Hospital | Phase 4 |
| Recruiting | A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia NCT06568471 | Hasten Biopharmaceutical Co., Ltd. | Phase 3 |
| Not Yet Recruiting | NPC1L1 Gene Polymorphism and the Efficacy and Safety of Hybutimibe NCT06641661 | Qianfoshan Hospital | — |
| Active Not Recruiting | Notification of Incidental Coronary Artery Calcium in Patients With Atherosclerotic Cardiovascular Disease (NO NCT05858879 | Stanford University | N/A |
| Recruiting | Test 2 Treat: Can we Improve the Testing and Treatment of High Cholesterol in Patients Who Have Been Hospitali NCT06471036 | Duke University | N/A |
| Completed | Telehealth Group Counseling and Preventive Care for Women NCT06404515 | Weill Medical College of Cornell University | N/A |
| Completed | Study of Obicetrapib & Ezetimibe Fixed Dose Combination on Top of Maximum Tolerated Lipid-Modifying Therapies NCT06005597 | NewAmsterdam Pharma | Phase 3 |
| Active Not Recruiting | Prospective Cohort Study of Panvascular Disease NCT06295861 | Second Affiliated Hospital, School of Medicine, Zhejiang University | — |
| Unknown | Study on the Composite Endpoint Event of PCSK9 Inhibitor in Patients With Very High Risk of ASCVD and Cancer NCT05976893 | Xiang Xie | Phase 4 |
| Enrolling By Invitation | Comparison of Low-Intensity Statin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Di NCT05579626 | Seung-Whan Lee, M.D., Ph.D. | Phase 4 |
| Terminated | Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors NCT05611307 | Indiana University | — |
| Recruiting | PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes NCT05390892 | Brigham and Women's Hospital | Phase 4 |
| Active Not Recruiting | Randomized Controlled Trial of Alert-Based Computerized Decision Support for Optimizing Low-Density Lipoprotei NCT05088759 | Brigham and Women's Hospital | N/A |
| Terminated | The Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9 Inhibitors (cvMOBIUS) NCT04197453 | Amgen | — |
| Unknown | Cardiometabolic Syndrome Response to Therapeutic Lifestyle Changes NCT04093440 | Holy Cross Hospital, Florida | N/A |
| Completed | Trial to Assess the Effect of Long Term Dosing of Inclisiran in Subjects With High CV Risk and Elevated LDL-C NCT03814187 | Novartis Pharmaceuticals | Phase 3 |
| Unknown | Thyroid Hormone Replacement for Subclinical Hypothyroidism and Dyslipidemia in ASCVD (ThyroHeart-Lipid Study) NCT03606824 | Shaochun.Li | N/A |
| Completed | High-Dose Statin Combined With Telmisartan vs Amlodipine on Glucose Metabolism in ASCVD Patients With IFG and NCT03474562 | Yuhan Corporation | Phase 4 |
| Completed | High-intensity Rosuvastatin and Moderate-intensity Rosuvastatin/Ezetimibe in ASCVD Patients NCT03494270 | Yuhan Corporation | Phase 4 |
| Completed | Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein C NCT03399370 | The Medicines Company | Phase 3 |
| Completed | Inclisiran for Subjects With ASCVD or ASCVD-Risk Equivalents and Elevated Low-density Lipoprotein Cholesterol NCT03400800 | The Medicines Company | Phase 3 |